de Klein A - Search Results

1

FOXD1 Is a Transcription Factor Important for Uveal Melanocyte Development and Associated with High-Risk Uveal Melanoma.

van den Bosch QCC, Nguyen JQN, Brands T, van den Bosch TPP, Verdijk RM, Paridaens D, Naus NC, de Klein A, Kiliç E, Brosens E; Rotterdam Ocular Melanoma Study Group. van den Bosch QCC, et al. Among authors: de klein a. Cancers (Basel). 2022 Jul 28;14(15):3668. doi: 10.3390/cancers14153668. Cancers (Basel). 2022. PMID: 35954332 Free PMC article.

2

A human and mouse homolog of the Schizosaccharomyces pombe rad1+ cell cycle checkpoint control gene.

Bluyssen HA, van Os RI, Naus NC, Jaspers I, Hoeijmakers JH, de Klein A. Bluyssen HA, et al. Among authors: de klein a. Genomics. 1998 Dec 1;54(2):331-7. doi: 10.1006/geno.1998.5582. Genomics. 1998. PMID: 9828137

3

Human and mouse homologs of the Schizosaccharomyces pombe rad17+ cell cycle checkpoint control gene.

Bluyssen HA, Naus NC, van Os RI, Jaspers I, Hoeijmakers JH, de Klein A. Bluyssen HA, et al. Among authors: de klein a. Genomics. 1999 Jan 15;55(2):219-28. doi: 10.1006/geno.1998.5642. Genomics. 1999. PMID: 9933569

4

Orbital chondrosarcoma developing in a patient with Paget disease.

Mooy CM, Naus NC, de Klein A, van den Bosch WA, Paridaens DA. Mooy CM, et al. Among authors: de klein a. Am J Ophthalmol. 1999 May;127(5):619-21. doi: 10.1016/s0002-9394(98)00405-x. Am J Ophthalmol. 1999. PMID: 10334366

5

Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.

Naus NC, van Drunen E, de Klein A, Luyten GP, Paridaens DA, Alers JC, Ksander BR, Beverloo HB, Slater RM. Naus NC, et al. Among authors: de klein a. Genes Chromosomes Cancer. 2001 Mar;30(3):267-73. Genes Chromosomes Cancer. 2001. PMID: 11170284

6

Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.

Naus NC, Verhoeven AC, van Drunen E, Slater R, Mooy CM, Paridaens DA, Luyten GP, de Klein A. Naus NC, et al. Among authors: de klein a. Clin Cancer Res. 2002 Feb;8(2):534-9. Clin Cancer Res. 2002. PMID: 11839674

7

Cellular radiosensitivity of primary and metastatic human uveal melanoma cell lines.

van den Aardweg GJ, Naus NC, Verhoeven AC, de Klein A, Luyten GP. van den Aardweg GJ, et al. Among authors: de klein a. Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2561-5. Invest Ophthalmol Vis Sci. 2002. PMID: 12147585

8

Dose fractionation effects in primary and metastatic human uveal melanoma cell lines.

van den Aardweg GJ, Kiliç E, de Klein A, Luyten GP. van den Aardweg GJ, et al. Among authors: de klein a. Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4660-4. doi: 10.1167/iovs.03-0151. Invest Ophthalmol Vis Sci. 2003. PMID: 14578382 Free article.

9

The RAS-BRAF kinase pathway is not involved in uveal melanoma.

Kiliç E, Brüggenwirth HT, Verbiest MM, Zwarthoff EC, Mooy NM, Luyten GP, de Klein A. Kiliç E, et al. Among authors: de klein a. Melanoma Res. 2004 Jun;14(3):203-5. doi: 10.1097/01.cmr.0000130006.46885.a0. Melanoma Res. 2004. PMID: 15179189

10

Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients.

Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo HB, Luyten GP, de Klein A. Kilic E, et al. Among authors: de klein a. Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2253-7. doi: 10.1167/iovs.04-1460. Invest Ophthalmol Vis Sci. 2005. PMID: 15980208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page